Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
If positive, GLP-3 may be positioned as one of the most significant research innovations in the obesity field in recent decades
Research suggests that increasing fiber-rich foods in our diet can help naturally stimulate GLP-1 (glucagon-like peptide-1) receptors
GLP-1s approved for diabetes include Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), and Victoza (liraglutide)
Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, Yong JN, Zeng RW, Chew NWS, Nah B, Kulkarni A, Siddiqui MS, Dan YY, Wong VW, Sanyal AJ, Noureddin M, Muthiah M, Ng CH
Though these drugs have been prescribed for people with diabetes for decades, the conversation around their use for weight loss has exploded in the past couple of years
But as more patients explore or discontinue these medications, functional and integrative medicine providers have a growing opportunity to offer complementary or alternative strategies that support similar metabolic pathwaysoften with fewer side effects
US$ 25.87
US$ 26.87
US$ 21.44
